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The limited primary antibody repertoire uses multiple
mechanisms to account for the large number of poten-
tial antigens. In this issue of Immunity, Sethi et al.
(2006) describe a new means for expanding the anti-
body repertoire, whereby a single antibody isomer
binds diverse antigens at different regions of the bind-
ing site.
A hallmark of the adaptive immune system is the capac-
ity to recognize virtually any antigen without having
been previously exposed to it. Given the very large num-
ber of clonotypically unique antibody or T cell receptor
(TCR) that can be generated by gene rearrangement
and N region substitution, it was initially believed that
adaptive immunity might be capable of generating
a unique antibody or TCR for every antigen or antigenic
peptide. However, subsequent estimates of the size of
the foreign peptide repertoire recognized by the TCRs
revealed that there are far more potentially immuno-
genic peptides in the environment of a mouse, or other
animals, than the animal has T cells (Mason, 1998). Sim-
ilar considerations probably apply to antibodies, for
which the size of the germline repertoire and the number
of circulating B cells appear insufficient to cover the al-
most infinite diversity of antigens to which an animal is
exposed. Multispecificity, or the ability of a single re-
ceptor molecule to engage multiple ligands, offers
a means for expanding the effective size of the antibody
or TCR repertoire, thereby providing comprehensive
coverage of the antigenic universe. Although multispec-
ificity (alternately referred to in the immunological litera-
ture as crossreactivity, promiscuity, or degeneracy) is
most often associated with antibodies and TCRs, it is
also an important property of other immune system re-
ceptors, such as natural killer (NK) cell receptors that
bind MHC or MHC-like molecules.
Two general mechanisms may be considered to ex-
plain multispecific ligand recognition by antibodies or
other receptors. In one case, an essentially rigid recep-
tor binding site may make different interactions with
structurally distinct ligand surfaces, without significant
conformational changes in the receptor (Figure 1A),
a mechanism termed ‘‘rigid adaptation’’ (McFarland
and Strong, 2003). Alternatively, the receptor may pos-
sess a degree of conformational flexibility that allows
it to reconfigure its binding site to accommodate di-
verse ligands (‘‘induced fit’’) (Figure 1B). X-ray crystallo-
graphic and thermodynamic studies have provided
ample evidence for both mechanisms in immune recog-
nition. For example, the lysozyme antibody D1.3 binds
both lysozyme and the idiotypic antibody E5.2 by using
essentially the same set of binding site residues, with
minimal structural adjustments in D1.3 or its ligands
(Fields et al., 1995). Atoms of E5.2 that contact D1.3
are positioned close to those of lysozyme that contact
D1.3, and most hydrogen bonds in the D1.3-lysozymeinterface are structurally equivalent to ones in the
D1.3-E5.2 interface. In another case of rigid adaptation,
the multispecific NK receptor NKG2D has evolved to
recognize, through a single binding site, the distantly re-
lated MHC-like ligands MICA, RAE-1b, and ULBP3,
again without recourse to conformational change in
the receptor (McFarland et al., 2003). Mutagenesis of
the corresponding complexes showed that the bind-
ing-free energy is unevenly distributed across the
NKG2D-ligand interfaces, such that energetic hot spots
are associated with structurally conserved receptor ele-
ments that interact with relatively conserved residues of
the ligands.
With respect to multispecificity mediated through
conformational flexibility of the receptor binding site,
binding of the germline antibody 7G12 to two structur-
ally unrelated ligands (porphyrin and jeffamine) was
found to involve two distinct conformational states of
7G12 (Yin et al., 2003). As a result of combining site re-
organization, 7G12 uses two partially overlapping sets
of residues to interact with these haptens. Similarly,
structural plasticity allows the Fc region of IgG to bind
ligands as diverse as protein G and rheumatoid factor
at a common site between its CH2 and CH3 domains
(DeLano et al., 2000). A comprehensive analysis of the
dinitrophenyl antibody SPE7 by X-ray crystallography
and presteady-state kinetics revealed a dynamic equi-
librium between different preexisting conformations,
each conferring a different antigen specificity (Figure 1B)
(James et al., 2003). One of these conformers displayed
a deep and narrow binding site for aromatic ligands,
such as the immunizing hapten, whereas another con-
former had a broad, shallow binding site that recog-
nized a protein ligand. In this view, proteins are an en-
semble of preexisting isomers, whereby one amino
acid sequence adopts multiple structures and, conse-
quently, multiple functions.
Based on these, and related, studies, one might rea-
sonably have supposed that the essential mechanisms
for achieving multispecificity had been discovered.
However, Salunke and colleagues (Sethi et al., 2006)
now report a new mechanism for expanding the primary
antibody repertoire, which they term ‘‘differential ligand
positioning.’’ The essential feature of this mechanism is
that a single antibody conformer may bind diverse anti-
gens at spatially distinct regions of the binding site
(Figure 1C). In this study, the authors first determined
the crystal structure of the germline antibody 36-65,
which was raised against the hapten azophenylarso-
nate, in unbound form. In all, four antigen-free antibody
structures were examined, which revealed a degree of
structural diversity consistent with previous thermody-
namic evidence that 36-65 is conformationally flexible
(Manivel et al., 2000), as expected for a germline anti-
body. No two molecules exhibited similar combining
site topologies, with differences attributable to varia-
tions in both backbone and side chain conformation.
The authors then determined the structure of 36-65 in
complex with three independent 12-mer peptides, iso-
lated by screening a phage-displayed random peptide
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360Figure 1. Mechanisms for Multispecific Ligand Recognition by Antibodies or Other Receptors
(A) Multispecificity through rigid adaptation. An essentially rigid receptor binding site recognizes structurally distinct ligands, without the need
for substantial conformational changes in the receptor.
(B) Multispecificity through conformational diversity. A conformationally flexible receptor binding site exists in dynamic equilibrium between dif-
ferent conformational states. Each conformation generates a distinct binding site topology, allowing the receptor to engage multiple ligands at
the same region of the binding site.
(C) Multispecificity through differential ligand positioning (Sethi et al., 2006). As in (B), the unligated receptor adopts different conformational
states. However, an altogether different conformational state mediates recognition of diverse ligands. In this case, multispecificity is conferred
not by conformational diversity but by ligand binding to spatially distinct regions of an otherwise topologically identical binding site (see text for
details).library, that bind 36-65 with affinities comparable to that
of the immunizing hapten. Although one might certainly
argue that this system is artificial insofar as the cross-
reactive peptides were not actually shown to elicit 36-
65-like antibodies if used as immunogens, there is no
compelling a priori reason to believe that the basic prin-
ciples emerging from this study should not apply in vivo.
Contrary to expectation, a single conformational state
of the 36-65 binding site mediated specific recognition
of all three peptide ligands (Figure 1C). Moreover, this
particular conformational state is distinct from any of the
conformers observed for the free antibody. Just as sur-
prisingly, the peptides bound to spatially separate sub-
sites within the combining site, where they adopt entirely
different conformations. These subsites show virtually
no overlap: ofw25 antibody residues in contact with the
peptide in one or the other complex, only two are shared
by all three complexes. Notably, these two residues
appear to help lock the 36-65 binding site into the single
conformation found in the complex structures.
How, then, does differential ligand positioning differ
from previously described mechanisms for multispe-
cific binding? In contrast to rigid adaptation (Figure 1A)
(Fields et al., 1995; McFarland et al., 2003), the bound
and unbound forms of antibody 36-65 display markedly
different binding site topologies, emphasizing the impor-
tance of conformational flexibility for this particular rec-
ognition mode. However, unlike other cases of induced
fit (Figure 1B), where multispecificity is mediated byconformational diversity (James et al., 2003), structurally
unrelated antigens bind a single conformer of 36-65,
which does not correspond to any unligated 36-35 struc-
ture. In principle, at least, a given antibody (or other re-
ceptor) may employ various combinations of these strat-
egies to further increase the number and diversity of
ligands it can recognize. For instance, a conformationally
rigid receptor could engage one set of ligands through
one set of binding site residues yet bind other ligands
at a different subsite by using other residues.
Have we now fully documented the entire range of
strategies receptors employ to achieve multispecificity?
Probably not, as other possibilities clearly exist. In the
case of TCRs, an important contributor to degenerate
recognition by a single TCR of diverse peptides during
thymic education and peripheral surveillance appears
to be imperfect shape and chemical complementarity
between the TCR and peptide in certain TCR-peptide-
MHC complexes (Li et al., 2005). This structural degener-
acy introduces a degree of tolerance to TCR recognition
of peptides bearing substitutions in TCR-contacting
positions, some of which could, in addition, improve
complementarity across an otherwise structurally con-
served interface. It is also conceivable that certain anti-
genic peptides alter the overall binding topology of
TCR to peptide-MHC, so that an entirely different set
of contacts mediates recognition in these crossreactive
complexes. The demonstration of multispecificity in both
adaptive (e.g., antibodies and TCRs) and innate (e.g., NK
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361receptors) immune systems underscores its critical role
in expanding immune surveillance as well as the impor-
tance of understanding this phenomenon at the molecu-
lar level.
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Some Nuts Are Tougher
to Crack than Others
In this issue of Immunity, Oestreich et al. (2006) show
that, during V(D)J recombination, RSSs may have dis-
tinct accessibility requirements. Some rely on an en-
hancer-intrinsic, general chromatin opening function,
whereas others require enhancer-promoter interac-
tions that direct local chromatin remodeling.
The antigen receptor repertoires of T and B lympho-
cytes are generated by the process of V(D)J recombina-
tion, which assembles mature T cell receptor (TCR) and
immunoglobulin (Ig) genes from variable (V), diversity
(D), and joining (J) gene segments during the early
stages of lymphocyte development. Individual TCR
and Ig loci are subject to distinct programs of V(D)J
recombination events, which vary as a function of lym-
phocyte lineage and developmental stage. Understand-
ing the basis for this regulation has been a longstanding
goal of molecular immunologists.
V(D)J recombination is initiated by the recombinase-
activating gene (RAG) proteins, which recognize recom-
bination signal sequences (RSSs) that flank TCR and Ig
coding gene segments. It has long been appreciated
that the developmental regulation of V(D)J recombina-
tion occurs primarily through changes in the accessibil-
ity of RSS substrates to the RAG proteins (Stanhope-
Baker et al., 1996). RSSs are facile substrates for RAG
proteins when present on naked DNA in vitro. However,
in lymphocyte nuclei in vivo, RSSs are embedded within
chromatin, a highly organized and highly compacted nu-
cleoprotein complex. Chromatin-embedded RSSs are
intrinsically inaccessible to RAG and require changes
in chromatin structure so that they can participate in
the V(D)J recombination reaction in vivo. Many lines of
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elements of antigen receptor loci, including enhancers
and promoters, as developmental regulators of both
V(D)J recombination and chromatin structure. However,
in molecular terms, what does it really take to make an
RSS accessible? How do enhancer and promoter ele-
ments accomplish this? The study by Oestreich et al.
(2006) in this issue of Immunity moves us several steps
closer to understanding these issues.
The initial step in TCRb recombination involves Db and
Jb segments situated within the 30 portion of the TCRb lo-
cus (Figure 1). Db1 can rearrange to any of six Jb1 gene
segments, and Db2 can rearrange to any of six functional
Jb2 gene segments. Previous gene targeting experi-
ments had shown that the TCRb enhancer (Eb), situated
30 of Cb2, was required for substantial levels of either
Db1-Jb1 or Db2-Jb2 rearrangement (Bouvier et al.,
1996). A promoter tightly juxtaposed with Db1 (PDb1)
was found to be essential for Db1-Jb1 rearrangement but
irrelevant for Db2-Jb2 rearrangement (Whitehurst et al.,
2000). An analogous promoter associated with Db2 is
likely critical for Db2-Jb2 rearrangement, but this has
yet to be demonstrated experimentally. Nevertheless it
is clear from the above that Db1-Jb1 rearrangement de-
pends on cooperation between Eb, which must act over
a distance of 15 kb, and PDb1, which acts more locally.
Oestreich et al. (2006) began their study with a detailed
analysis of chromatin structure across the Db and Jb
segments in mice carrrying wild-type TCRb alleles or
alleles lacking either PDb1 or Eb. As a surrogate for
RSS accessibility to RAG, they measured the accessibil-
ity of defined restriction sites to digestion with restriction
enzymes introduced into permeabilized nuclei of imma-
ture thymocytes. As expected, they found that a HinF1
site in the Db1 RSS could only be cleaved efficiently in
the presence of both PDb1 and Eb. However, at a series
of other restriction sites extending from a point only
a few nucleosomes downstream of the Db1 RSS to the
Jb1.6 RSS, accessibility was highly dependent on Eb
but minimally dependent on PDb1. These conclusions
